| 1 |
Wang W, Liu CF. Sepsis heterogeneity[J]. World J Pediatr, 2023, 19 (10): 919-927.
|
| 2 |
Schuurman AR, Sloot PMA, Wiersinga WJ, et al. Embracing complexity in sepsis[J]. Crit Care, 2023, 27 (1): 102.
|
| 3 |
Park I, Kim M, Choe K, et al. Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury[J]. Eur Respir J, 2019, 53 (3): 1800786.
|
| 4 |
Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey[J]. Crit Care Med, 2020, 48 (3): e209-e218.
|
| 5 |
Yoo JW, Ju S, Lee SJ, et al. Red cell distribution width/albumin ratio is associated with 60-day mortality in patients with acute respiratory distress syndrome[J]. Infect Dis (Lond), 2020, 52 (4): 266-270.
|
| 6 |
Wang Z, Wang Z. The role of macrophages polarization in sepsis-induced acute lung injury[J]. Front Immunol, 2023 (14): 1209438.
|
| 7 |
Zou S, Jie H, Han X, et al. The role of neutrophil extracellular traps in sepsis and sepsis-related acute lung injury[J]. Int Immunopharmacol, 2023, 124 (Pt A): 110436.
|
| 8 |
Gong H, Chen Y, Chen M, et al. Advanced development and mechanism of sepsis-related acute respiratory distress syndrome[J]. Front Med (Lausanne), 2022 (9): 1043859.
|
| 9 |
Zhou X, Liao Y. Gut-lung crosstalk in sepsis-induced acute lung injury[J]. Front Microbiol, 2021 (12): 779620.
|
| 10 |
Sun B, Lei M, Zhang J, et al. Acute lung injury caused by sepsis: how does it happen?[J]. Front Med (Lausanne), 2023 (10): 1289194.
|
| 11 |
Guo J, Chen X, Wang C, et al. Liraglutide alleviates acute lung injury and mortality in pneumonia-induced sepsis through regulating surfactant protein expression and secretion[J]. Shock, 2024, 61 (4): 601-610.
|
| 12 |
Jiao Y, Zhang T, Zhang C, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury[J]. Crit Care, 2021, 25 (1): 356.
|
| 13 |
Xie H, Chai H, Du X, et al. Overexpressing long non-coding RNA OIP5-AS1 ameliorates sepsis-induced lung injury in a rat model via regulating the miR-128-3p/Sirtuin-1 pathway[J]. Bioengineered, 2021, 12 (2): 9723-9738.
|
| 14 |
Yang J, Nie J, Ma X, et al. Targeting PI3K in cancer: mechanisms and advances in clinical trials[J]. Mol Cancer, 2019, 18 (1): 26.
|
| 15 |
Tian J, Li Y, Mao X, et al. Effects of the PI3K/Akt/HO-1 pathway on autophagy in a sepsis-induced acute lung injury mouse model[J]. Int Immunopharmacol, 2023, 124 (Pt B): 111063.
|
| 16 |
Guo W, Hu Z. SRPK1 promotes sepsis-induced acute lung injury via regulating PI3K/AKT/FOXO3 signaling[J]. Immunopharmacol Immunotoxicol, 2023, 45 (2): 203-212.
|
| 17 |
Li T, Geng Z, Zhang J, et al. BP5 alleviates endotoxemia-induced acute lung injury by activating Nrf2 via dual regulation of the Keap1-Nrf2 interaction and the Akt (Ser473)/GSK3β (Ser9)/Fyn pathway[J]. Free Radic Biol Med, 2022, 193 (Pt 1): 304-318.
|
| 18 |
Kim GO, Park DH, Bae JS. Procyanidin B2 attenuates sepsis-induced acute lung injury via regulating Hippo/Rho/PI3K/NF-κB signaling pathway[J]. Int J Mol Sci, 2023, 24 (9): 7930.
|
| 19 |
Margaria JP, Moretta L, Alves-Filho JC, et al. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury[J]. Biomedicines, 2022, 10 (4): 756.
|
| 20 |
Hu X, Xu Q, Wan H, et al. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis[J]. Lab Invest, 2020, 100 (6): 801-811.
|
| 21 |
Deleyto-Seldas N, Efeyan A. The mTOR-autophagy axis and the control of metabolism[J]. Front Cell Dev Biol, 2021 (9): 655731.
|
| 22 |
Liao SX, Sun PP, Gu YH, et al. Autophagy and pulmonary disease[J]. Ther Adv Respir Dis, 2019 (13): 1753466619890538.
|
| 23 |
Li J, Li M, Li L, et al. Hydrogen sulfide attenuates ferroptosis and stimulates autophagy by blocking mTOR signaling in sepsis-induced acute lung injury[J]. Mol Immunol, 2022 (141): 318-327.
|
| 24 |
Wei X, Yi X, Lv H, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy[J]. Cell Death Dis, 2020, 11 (8): 657.
|
| 25 |
Xu F, Yuan J, Tian S, et al. MicroRNA-92a serves as a risk factor in sepsis-induced ARDS and regulates apoptosis and cell migration in lipopolysaccharide-induced HPMEC and A549 cell injury[J]. Life Sci, 2020 (256): 117957.
|
| 26 |
Wang Z, Guo Z, Wang X, et al. Reduning alleviates sepsis-induced acute lung injury by reducing apoptosis of pulmonary microvascular endothelial cells[J]. Front Immunol, 2023 (14): 1196350.
|
| 27 |
Peng F, Chang W, Sun Q, et al. HGF alleviates septic endothelial injury by inhibiting pyroptosis via the mTOR signalling pathway[J]. Respir Res, 2020, 21 (1): 215.
|
| 28 |
Capece D, Verzella D, Flati I, et al. NF-κB: blending metabolism, immunity, and inflammation[J]. Trends Immunol, 2022, 43 (9): 757-775.
|
| 29 |
Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduct Target Ther, 2020, 5 (1): 209.
|
| 30 |
Alharbi KS, Fuloria NK, Fuloria S, et al. Nuclear factor-kappa B and its role in inflammatory lung disease[J]. Chem Biol Interact, 2021 (345): 109568.
|
| 31 |
Millar MW, Fazal F, Rahman A. Therapeutic targeting of NF-κB in acute lung injury: a double-edged sword[J]. Cells, 2022, 11 (20): 3317.
|
| 32 |
Sun B, Bai L, Li Q, et al. Knockdown of angiopoietin-like 4 suppresses sepsis-induced acute lung injury by blocking the NF-κB pathway activation and hindering macrophage M1 polarization and pyroptosis[J]. Toxicol In Vitro, 2024 (94): 105709.
|
| 33 |
Chang B, Wang Z, Cheng H, et al. Acacetin protects against sepsis-induced acute lung injury by facilitating M2 macrophage polarization via TRAF6/NF-κB/COX2 axis[J]. Innate Immun, 2024, 30 (1): 11-20.
|
| 34 |
Wang R, Li Q, Wu P, et al. Fe-capsaicin nanozymes attenuate sepsis-induced acute lung injury via NF-κB signaling[J]. Int J Nanomedicine, 2024 (19): 73-90.
|
| 35 |
Zhang X, Wang X, Sun L, et al. Tofacitinib reduces acute lung injury and improves survival in a rat model of sepsis by inhibiting the JAK-STAT/NF-κB pathway[J]. J Inflamm (Lond), 2023, 20 (1): 5.
|
| 36 |
Philips RL, Wang Y, Cheon H, et al. The JAK-STAT pathway at 30: much learned, much more to do[J]. Cell, 2022, 185 (21): 3857-3876.
|
| 37 |
Clere-Jehl R, Mariotte A, Meziani F, et al. JAK-STAT targeting offers novel therapeutic opportunities in sepsis[J]. Trends Mol Med, 2020, 26 (11): 987-1002.
|
| 38 |
Zhang Y, Gao Z, Jiang F, et al. JAK-STAT signaling as an ARDS therapeutic target: status and future trends[J]. Biochem Pharmacol, 2023 (208): 115382.
|
| 39 |
Lou Y, Huang Z, Wu H, et al. Tranilast attenuates lipopolysaccharide-induced lung injury via the CXCR4/JAK2/STAT3 signaling pathway[J]. Mol Med Rep, 2022, 26 (1): 220.
|
| 40 |
Lin Y, Wongkrajang K, Shen X, et al. Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo[J]. Bioorg Med Chem, 2022 (66): 116811.
|
| 41 |
Puigdevall L, Michiels C, Stewardson C, et al. JAK/STAT: why choose a classical or an alternative pathway when you can have both?[J]. J Cell Mol Med, 2022, 26 (7): 1865-1875.
|
| 42 |
Tao Y, Xu X, Yang B, et al. Mitigation of sepsis-induced acute lung injury by BMSC-derived exosomal miR-125b-5p through STAT3-mediated suppression of macrophage pyroptosis[J]. Int J Nanomedicine, 2023 (18): 7095-7113.
|
| 43 |
Qian T, Qi B, Fei Y, et al. PLD2 deletion alleviates disruption of tight junctions in sepsis-induced ALI by regulating PA/STAT3 phosphorylation pathway[J]. Int Immunopharmacol, 2023 (114): 109561.
|
| 44 |
Ahmadi A, Ahrari S, Salimian J, et al. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics[J]. Cell Commun Signal, 2023, 21 (1): 314.
|
| 45 |
Shen J, Ma X. miR-374a-5p alleviates sepsis-induced acute lung injury by targeting ZEB1 via the p38 MAPK pathway[J]. Exp Ther Med, 2022, 24 (3): 564.
|
| 46 |
Zhou KL, He YR, Liu YJ, et al. IL-17A/p38 signaling pathway induces alveolar epithelial cell pyroptosis and hyperpermeability in sepsis-induced acute lung injury by activating NLRP3 inflammasome[J]. Adv Biol (Weinh), 2023, 7 (12): e2300220.
|
| 47 |
Zhao Y, Kuca K, Wu W, et al. Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases[J]. Alzheimers Dement, 2022, 18 (1): 152-158.
|
| 48 |
Zhang ZK, Zhou Y, Cao J, et al. Rosmarinic acid ameliorates septic-associated mortality and lung injury in mice via GRP78/IRE1α/JNK pathway[J]. J Pharm Pharmacol, 2021, 73 (7): 916-921.
|
| 49 |
Zheng Q, Wang YC, Liu QX, et al. FK866 attenuates sepsis-induced acute lung injury through c-jun-N-terminal kinase (JNK)-dependent autophagy[J]. Life Sci, 2020 (250): 117551.
|
| 50 |
Yang J, Do-Umehara HC, Zhang Q, et al. miR-221-5p-mediated downregulation of JNK2 aggravates acute lung injury[J]. Front Immunol, 2021 (12): 700933.
|
| 51 |
Liao J, Yang J, Li X, et al. Discovery of the diphenyl 6-oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide analogue J27 for the treatment of acute lung injury and sepsis by targeting JNK2 and inhibiting the JNK2-NF-κB/MAPK pathway[J]. J Med Chem, 2023, 66 (17): 12304-12323.
|
| 52 |
Liang J, Zhang J, Fan J, et al. ANXA3 interference inactivates ERK/ELK1 pathway to mitigate inflammation and apoptosis in sepsis-associated acute lung injury[J]. Mol Immunol, 2024 (167): 25-33.
|